Apollomics Inc. (APLM) stock
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
$17.68+0.38 (+2.20%)
Close on Nov 13, 2026Market cap $38.83MP/E –Yield –
Apollomics cash
Cash and short-term investments held at the end of each period.
Apollomics's cash was $3.28M at Dec 31, 2025. For fiscal 2025 it was $3.28M, down 66.5% from the year before. The highest annual figure on record is $130.65M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.28M | -66.5% |
| FY2024 | Dec 31, 2024 | $9.77M | -69.5% |
| FY2023 | Dec 31, 2023 | $32.06M | -1.9% |
| FY2022 | Dec 31, 2022 | $32.68M | -30.1% |
| FY2021 | Dec 31, 2021 | $46.74M | -64.2% |
| FY2020 | Dec 31, 2020 | $130.65M | +239.5% |
| FY2019 | Dec 31, 2019 | $38.49M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $3.28M | -89.8% |
| Q2 FY2025 | Jun 30, 2025 | $2.09M | -91.7% |
| Q4 FY2024 | Dec 31, 2024 | $9.77M | -70.1% |
| Q2 FY2024 | Jun 30, 2024 | $25.93M | -48.9% |
| Q4 FY2023 | Dec 31, 2023 | $32.06M | -31.4% |
| Q2 FY2023 | Jun 30, 2023 | $25.30M | -80.6% |
| Q4 FY2022 | Dec 31, 2022 | $32.68M | -15.1% |
| Q2 FY2022 | Jun 30, 2022 | $50.70M | – |
| Q4 FY2021 | Dec 31, 2021 | $46.74M | – |
| Q4 FY2020 | Dec 31, 2020 | $130.65M | – |
| Q4 FY2019 | Dec 31, 2019 | $38.49M | – |
See a number that looks wrong?